Antibiotic prescribing in paediatric populations: a comparison between Viareggio, Italy and Funen, Denmark

Gaia Lusini1, Francesco Lapi, Benocci Sara

  • 1Hospital Pharmacy, ASL 9 Hospital, 58100 Grosseto, Italy.

Insights

Paediatric antibiotic prescribing rates were significantly higher in Viareggio, Italy, compared to Funen, Denmark. These findings suggest potential overuse and misuse of antibiotics in the Italian pediatric population, contributing to antibiotic resistance.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Public Health Policy

Background:

  • High antibiotic prescribing rates in children contribute to antibiotic resistance.
  • Limited research exists on pediatric antibiotic use in Italy.
  • International comparisons are needed to assess prescribing patterns.

Purpose of the Study:

  • To compare pediatric antibiotic prescribing rates between Viareggio, Italy, and Funen, Denmark.
  • To identify differences in antibiotic utilization between the two regions.
  • To inform strategies for appropriate antibiotic use in pediatric populations.

Main Methods:

  • Utilized 2003 reimbursement and pharmacy dispensing data.
  • Calculated antibiotic use as Defined Daily Doses (DDD) per 1000 inhabitants per day (DDD/TID).
  • Stratified data by age groups: 0-4, 5-9, 10-14, and 15-19 years.

Main Results:

  • Viareggio showed higher overall pediatric antibiotic prescribing (67 DDD/TID) than Funen (35 DDD/TID).
  • Amoxicillin and amoxicillin/enzyme inhibitors were most frequent in Viareggio; phenoxymethylpenicillin and amoxicillin in Funen.
  • Cephalosporins, particularly cefaclor, were notably used in younger age groups in Viareggio.

Conclusions:

  • Paediatric antibiotic prescription rates are substantially higher in Viareggio than in Funen.
  • Data indicate possible overuse and misuse of antibiotics in the Italian pediatric population.
  • Findings highlight the need for targeted interventions to optimize antibiotic prescribing in Italy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Antibiotic Selection00:57

Antibiotic Selection

Overview